Atara Biotherapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell ATRA and other ETFs, options, and stocks.About ATRA
Atara Biotherapeutics, Inc. is an allogeneic T-cell immunotherapy company, which engages in the development of transformative therapies for patients with serious diseases including solid tumors, hematologic cancers, and autoimmune diseases. It also delivers off-the-shelf treatments to patients with high unmet medical need.
CEOAnhco Nguyen
CEOAnhco Nguyen
Employees153
Employees153
HeadquartersThousand Oaks, California
HeadquartersThousand Oaks, California
Founded2012
Founded2012
Employees153
Employees153
ATRA Key Statistics
Market cap100.22M
Market cap100.22M
Price-Earnings ratio6.28
Price-Earnings ratio6.28
Dividend yield—
Dividend yield—
Average volume75.54K
Average volume75.54K
High today$14.28
High today$14.28
Low today$13.19
Low today$13.19
Open price$13.19
Open price$13.19
Volume43.85K
Volume43.85K
52 Week high$18.71
52 Week high$18.71
52 Week low$5.01
52 Week low$5.01
Stock Snapshot
With a market cap of 100.22M, Atara Biotherapeutics(ATRA) trades at $13.76. The stock has a price-to-earnings ratio of 6.28.
As of 2025-11-16, Atara Biotherapeutics(ATRA) stock has fluctuated between $13.19 and $14.28. The current price stands at $13.76, placing the stock +4.3% above today's low and -3.6% off the high.
The Atara Biotherapeutics(ATRA)'s current trading volume is 43.85K, compared to an average daily volume of 75.54K.
In the last year, Atara Biotherapeutics(ATRA) shares hit a 52-week high of $18.71 and a 52-week low of $5.01.
In the last year, Atara Biotherapeutics(ATRA) shares hit a 52-week high of $18.71 and a 52-week low of $5.01.
People also own
Based on the portfolios of people who own ATRA. This list is generated using Robinhood data, and it’s not a recommendation.